Dynamic imaging: Track signaling and transcriptional responses
Pathology-based assays: Evaluate pathway activity under disease conditions
High-content drug screening: Efficiently test multiple compounds
Real-time tumor tracking: Monitor progression in animal models
Non-invasive assays: In vitro and in vivo studies using optical or fluorescence methods
وصف
The RD MAPK-ERK Pathway SRE RFP Reporter stable cell line is a genetically modified human embryonal rhabdomyosarcoma (RMS) cell line, featuring a stable reporter system for dynamic, non-invasive analysis of cellular behavior and molecular signaling. This dual integration of a disease-relevant cancer model with a reporter readout offers a potent tool for both fundamental and translational cancer research.